
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
Lego's $650 Pokémon set is already sold out as demand, preorders surge13.01.2026 - 2
Ocean side Locations for a Family Excursion01.01.1 - 3
Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality25.09.2023 - 4
Vote In favor of Your Number one Sort Of Blossoms05.06.2024 - 5
Rediscovering Euphoria: Individual Accounts of Conquering Despondency22.09.2023
Nuno Loureiro, MIT physicist, fatally shot at home; police investigate
Visiting This Japanese City Just Got A Little More Expensive (Here's What Travelers Should Know)
Five killed in Israeli air strikes on tents near Khan Younis, medics say
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
Careful Connections: Building Association and Trust
Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
Treasure trove found in Egyptian tomb solves ancient mystery
I’m a doctor. Here are 10 science-backed tips to help you get healthier.
5 Critical Rules For Business Regulation Chiefs












